Clinical Trial Update: Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 [Phase 1]

View source ↗

Summary

Phase 1 study assessing tolerability, pharmacokinetics and pharmacodynamics of six multiple rising-dose regimens of BIA 5-453 in hypertension and chronic heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• BIA 5-453

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Hypertension, Chronic Heart Failure | Phase 1 | Status: COMPLETED